Screening COVID-19 by Swaasa AI platform using cough sounds: a cross-sectional study

• Published in: Scientific reports Vol. 13; no. 1; p. 18284
• Main Authors: Pentakota, Padmalatha, Rudraraju, Gowrisree, Sripada, Narayana Rao, Mamidgi, Baswaraj, Gottipulla, Charishma, Jalukuru, Charan, Palreddy, Shubha Deepti, Bhoge, Nikhil Kumar Reddy, Firmal, Priyanka, Yechuri, Venkat, Jain, Manmohan, Peddireddi, Venkata Sudhakar, Bhimarasetty, Devi Madhavi, Sreenivas, S., Prasad K, Kesava Lakshmi, Joshi, Niranjan, Vijayan, Shibu, Turaga, Sanchit, Avasarala, Vardhan
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 25.10.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 692/699/255; 692/700; Artificial intelligence; Cough; COVID-19; Cross-sectional studies; Disease; Disease spread; Humanities and Social Sciences; multidisciplinary; Neural networks; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-45104-4

The Advent of Artificial Intelligence (AI) has led to the use of auditory data for detecting various diseases, including COVID-19. SARS-CoV-2 infection has claimed more than six million lives to date and therefore, needs a robust screening technique to control the disease spread. In the present study we created and validated the Swaasa AI platform, which uses the signature cough sound and symptoms presented by patients to screen and prioritize COVID-19 patients. We collected cough data from 234 COVID-19 suspects to validate our Convolutional Neural Network (CNN) architecture and Feedforward Artificial Neural Network (FFANN) (tabular features) based algorithm. The final output from both models was combined to predict the likelihood of having the disease. During the clinical validation phase, our model showed a 75.54% accuracy rate in detecting the likely presence of COVID-19, with 95.45% sensitivity and 73.46% specificity. We conducted pilot testing on 183 presumptive COVID subjects, of which 58 were truly COVID-19 positive, resulting in a Positive Predictive Value of 70.73%. Due to the high cost and technical expertise required for currently available rapid screening methods, there is a need for a cost-effective and remote monitoring tool that can serve as a preliminary screening method for potential COVID-19 subjects. Therefore, Swaasa would be highly beneficial in detecting the disease and could have a significant impact in reducing its spread.